Journals / Turkish Journal of Urology / 2016 / Cilt: 42 - Sayı: 3

The level of knowledge and awareness about prostate cancer in the Turkish male and the relevant effective factors

Pages
134–139
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We think that social and medical impact of the disease can be decreased with the planning of effective methods based on sociocultural and economic factors

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our aim was to determine the general knowledge and awareness levels, information sources, and the state of medical check-up for prostate cancer (PCa) and relevant effective factors.Material and methods: The participants were asked to answer to 14 questions of a questionnaire about age, education, economic and social condition, knowledge about PCa, state of being examined and their related factors.
📊
Key Findings & Data:Two groups were formed according to age ( 60 years) and variations according to ages were investigated.Results: Two hundred and ninety-three men with an average age of 57 years were included in the study.
💡
Conclusion & Impact:We think that social and medical impact of the disease can be decreased with the planning of effective methods based on sociocultural and economic factors
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Our aim was to determine the general knowledge and awareness levels, information sources, and the state of medical check-up for prostate cancer (PCa) and relevant effective factors.Material and methods: The participants were asked to answer to 14 questions of a questionnaire about age, education, economic and social condition, knowledge about PCa, state of being examined and their related factors. According to demographic characteristics of the participants, levels of awareness about PCa, sources of information, affecting factors and their interrelationships were examined. Two groups were formed according to age ( 60 years) and variations according to ages were investigated.Results: Two hundred and ninety-three men with an average age of 57 years were included in the study. Our findings showed that 68.3% of the participants were thinking that PCa is a frequently seen disease, 88.4% were thinking that it can be treated and 62.8% of men specified that their information sources are doctors. We also found that 60.8% of the participants had not undergone prostate examination and prostate specific antigen (PSA) control. The most reason for not having annual examinations was (44.4%) “negligence”. Significantly greater number of men with higher education (high school/university) were highly informed about PCa (p=0.037). Check-up rates were statistically significantly higher among men with intermediate income (p=0.041). Curability of PCa diagnosed at an early stage was acknowledged by statistically higher number of individuals under the age 60 (p 60 years.Conclusion: Although PCa has a high prevalence and mortality rates, personal and social information and sensitivity levels must be increased as it can be treated if diagnosed at an early stage. We think that social and medical impact of the disease can be decreased with the planning of effective methods based on sociocultural and economic factors

🔖

Cite This Article

TURKAN, S., DOĞAN, F., EKMEKÇİOĞLU, O., ÇOLAK, A., KALKAN, M., ŞAHİN, C. (2016). The level of knowledge and awareness about prostate cancer in the Turkish male and the relevant effective factors. Turkish Journal of Urology, Cilt: 42 - Sayı: 3, 134–139. https://ajindex.com/articles/380023

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:359-86. [CrossRef] 2. Nelen V. Epidemiology of prostate cancer. Recent Results Cancer Res 2007;175:1-8. [CrossRef] 3. Tao ZQ, Shi AM, Wang KX, Zhang WD. Epidemiology of prostate cancer: current status. Eur Rev Med Pharmacol Sci 2015;19:805- 12. 4. Shore N. Management of early-stage prostate cancer. Am J Manag Care 2014;20:260-72. 5. Zorlu F, Zorlu R, Divrik RT, Eser S, Yorukoglu K. Prostate cancer incidence in Turkey: an epidemiological study. Asian Pac J Cancer Prev 2014;15:9125-30. [CrossRef] 6. Merglen A, Schmidlin F, Fioretta G, Verkooijen HM, Rapiti E, Zanetti R, et al. Short and long term mortality with localized prostate cancer. Arch Intern Med 2007;167:1944-50. [CrossRef] 7. Ceber E, Cakir D, Ogce F, Simsir A, Cal C, Ozentürk G. Why do men refuse prostate cancer screening? Demographic analysis in Turkey. Asian Pac J Cancer Prev 2008;9:387-90. 8. Winterich JA, Grzywacz JG, Quandt SA, Clark PE, Miller DP, Acuna J, et al. Men’s knowledge and beliefs about prostate cancer:education, race, and screening statu. Ethn Dis 2009;19:199-203. 9. Casey RG, Rea DJ, McDermott T, Grainger R, Butler M, Thornhill JA. Prostate cancer knowledge in Irish Man. J Cancer Educ 2012;27:120-31. [CrossRef] 10. Dutkiewcz S, Jędrzejewska S. Education concerning carcinoma of prostate and its early detection. Cent European J Urol 2011;64:15- 20. [CrossRef] 11. Heidenreich A, Abrahamsson PA, Artibani W, Catto J, Montorsi F, Van Poppel H, et al. Early detection of prostate cancer: European Association of Urology recommendation. Eur Urol 2013;64:347-54. [CrossRef] 12. Bashir MN. Epidemiology of prostate cancer. Asian Pac J Cancer Prev 2015;16:5137-41. [CrossRef] 13. Stanford JL, Ostrander EA. Familial prostate cancer. Epidemiol Rev 2001;23:19-23. [CrossRef] 14. Obana M, O’Lawrence H. prostate cancer screenıng: psa test awareness among adult males. J Health Hum Serv Adm 2015;38:17-43. 15. Chung TD, Park II, Ignacio L, Catchatourian R, Kopnick M, Davison E, et al. Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trial. Int J Cancer 2000;90:302-4. [CrossRef] 16. Weinrich SP, Reynolds WA Jr, Tingen MS, Starr CR. Barriers to prostate cancer screening. Cancer Nurs 2000;23:117-21. [CrossRef]